Watch us on YouTube Live at 8:30AM EST
Squeeze Stocks – AMC continues to lead looking to add to yesterday’s impressive rally that saw both momentum and volume slow in other “meme” stocks. Another recent participant in the retail focused rally, GEO Group shares are up sharply premarket on news the company’s CEO purchased an additional 166.6K shares. AMC, GEO, BB
Adobe Inc – Posted its quarterly earnings results after the bell Thursday. The software company reported $3.03 EPS for the quarter, beating the consensus estimate of $2.81 by $0.22, RTT News reports. The firm had revenue of $3.84 billion during the quarter, compared to analysts’ expectations of $3.73 billion. Adobe had a return on equity of 36.30% and a net margin of 40.68%. The company’s revenue for the quarter was up 22.7% on a year-over-year basis.
Orphazyme AS – The stock has tumbled more than 50% premarket after the FDA gave thumbs down for their arimoclomol highly anticipated treatment; following the decision the company cut its FY21 outlook.
Palantir Technologies – The FAA has selects Palantir for aircraft certification safety monitoring solutions, the company will provide a data analytics tool that will help advance the agency’s modernization objectives for aviation safety.
NVIDIA Corp – Back on watch after reaching another fresh all-time high Thursday, Jefferies analysts increased their PT on the stock this morning to a street high $854. The company also said it plans to invest at least $100 million in UK supercomputer.
Arrival SA – The global company creating electric vehicles is under pressure this morning after announcing that its registration statement on Form F-1 was declared effective by the U.S. Securities and Exchange Commission on June 17, 2021. Such declaration does not imply that the SEC has approved or opined on the merits of the recent offering.
UTime Ltd – Chinese mobile device producer bouncing back after yesterday’s steep decline, micro float (3m shares) fell nearly 80% in Thursday’s session on heavy volume.
Anpac Bio-Medical Sciences – Said it has been granted a U.S. patent for its medical devices for both disease detection and treatment applications, the patent covers device structures and methods to modify biological samples for treatment purposes. The company says its newly launched cancer treatment joint venture has secured over $4 million of capital contributions from multiple funding sources.
Geron Corp – Rallying on positive data from blood cancer treatment study.
Athira Pharma – Shares of drug developer are sharply lower after CEO Dr Leen Kawas was put on temporary leave pending review late Thursday. The company’s board will review actions stemming from Kawas’ doctoral research at Washington State University.